Google
HKPD — HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES (Healthcare >> Medical Distribution)
HKPD FAQ
What is HKPD's P/E ratio?
HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES (HKPD) currently trades at a P/E ratio of 14.79.
What is HKPD's ROE?
HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES reports a Return on Equity (ROE) of -17.16%.
What is HKPD's dividend yield?
HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES offers a dividend yield of 0.00%.
What is HKPD's Deepscope Quality Score?
Deepscope rates HKPD's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy HKPD?
Deepscope's AI Timing Score for HKPD is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does HKPD belong to?
HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES is classified under the Healthcare >> Medical Distribution sector on the NASDAQ exchange.
|
USD 0.52
Price
-0.00
(-0.25%)
Day Change
|
|
|---|
HKPD, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.52 |
| PBV / Sector |
2.38 / -3.75
|
| Earning Per Share | -0.04 |
| PE / Sector |
14.79 / 17.62
|
| PEG or PE/Growth / Sector |
N/A / 179.45
|
| Average 1M Daily Value |
0.21 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
47% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:13 |
| Symbol | HKPD |
| Name | HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITED ORDINARY SHARES |
| Sector | Healthcare >> Medical Distribution |
| Market | NASDAQ |
| Listed Shares | 16.35 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12.25 / 39,342.21 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Well Town Industrial Building, Yau Tong, Hong Kong, 999077
Phone: 852 2618 9289
Website: https://www.9zt.hk
Description: Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
ME vs SECTOR Healthcare >> Medical Distribution
Click a bubble to view stock details · Bubble size represents market capitalization share
